Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG Blocker eliminates heterophilic antibody interference, ensuring clinical-grade purity and mitigating thromboembolic risks Yongin, South Korea, 6th April 2026, ZEX PR WIRE — GC Biopharma (006280.KS), a global leader in plasma-derived protein therapies, today announced a significant advancement in the …






